| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -95,000 | 100% | $30.61 | -$2,908,329 |
| Net | -1 | -95,000 | -100% | -$2,908,329 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| MARK L. BAUM | CHIEF EXECUTIVE OFFICER, Director | $140,527,277 | 12 Dec 2025 | ||
| Opaleye Management Inc. | 10%+ Owner | $104,480,098 | -$2,908,329 | -2.7% | 09 Jun 2025 |
| ANDREW R. BOLL | President And Cfo | $38,174,083 | 12 Dec 2025 | ||
| JOHN P. SAHAREK | CEO & President, ImprimisRx | $10,791,989 | 03 Apr 2025 | ||
| RICHARD L. LINDSTROM MD | Director | $1,022,671 | 30 Sep 2022 | ||
| Martin A. Makary | Director | $364,950 | 14 Jun 2024 | ||
| Teresa Sparks | Director | 21 Jun 2023 | |||
| Robert Kammer | Director | 25 Jun 2021 | |||
| R. Lawrence Van Horn | Director | 21 Jun 2023 | |||
| Francis Mullery | CEO, ImprimisRx | 06 Oct 2025 | |||
| LAUREN P. SILVERNAIL | Director | 20 Jun 2025 | |||
| Amir Shojaei | Chief Scientific Officer | 06 Jan 2025 | |||
| Perry J. Sternberg | Director | 20 Jun 2025 | |||
| Randall Pollard | Chief Accounting Officer | 01 Sep 2025 | |||
| Adrienne L. Graves | Director | 20 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|